• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 暴露前预防植入的选择偏好和优先事项:南非豪登省妇女和少女参与的离散选择实验结果。

HIV Pre-exposure Prophylaxis Implant Stated Preferences and Priorities: Results of a Discrete Choice Experiment Among Women and Adolescent Girls in Gauteng Province, South Africa.

机构信息

HIV/TB Department, Population Services International (PSI), Washington, DC, USA.

Strategy & Insights Department, PSI, 1120 19th Street NW, Suite 600, Washington, DC, 20036, USA.

出版信息

AIDS Behav. 2022 Sep;26(9):3099-3109. doi: 10.1007/s10461-022-03658-w. Epub 2022 Mar 31.

DOI:10.1007/s10461-022-03658-w
PMID:35360893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9371991/
Abstract

For adolescent girls (AG) and young women (YW), adherence barriers may limit the effectiveness of daily oral HIV pre-exposure prophylaxis (PrEP). Due to its low-burden and long-lasting product attributes, PrEP implants could remove some of the critical adherence barriers of oral PrEP products for individuals at risk of HIV. To explore stated preferences for a long-acting PrEP implant, we conducted a quantitative survey and discrete choice experiment with AG (ages 15-17), YW (18-34), and female sex workers (FSW; ≥ 18) in Gauteng Province, South Africa. We completed 600 quantitative surveys across the three subgroups of women. Respondents stated preference for an implant that provided longer HIV protection (24 months versus 6 months) and required a single insertion. They stated that they preferred a biodegradable implant that could be removed within 1 month of insertion. Respondents had no preference for a particular insertion location. Overall, 78% of respondents said they would be likely (33%) or very likely (45%) to use a PrEP implant were one available, with the majority (82%) stating preference for a product that would provide dual protection against HIV and unintended pregnancies. To reduce their risk of HIV, AG, YW, and FSW in our survey reported a strong willingness to use long-acting, highly-effective, dissolvable PrEP implants.

摘要

对于少女(AG)和年轻女性(YW),坚持用药的障碍可能会影响每日口服 HIV 暴露前预防(PrEP)的效果。由于 PrEP 植入物的低负担和长效产品属性,它可能会消除某些高危人群口服 PrEP 产品的关键坚持用药障碍。为了探索长效 PrEP 植入物的偏好,我们在南非豪登省开展了一项定量调查和离散选择实验,对象是 AG(15-17 岁)、YW(18-34 岁)和女性性工作者(FSW;≥18 岁)。我们在这三个女性亚组中完成了 600 项定量调查。受访者对能提供更长 HIV 保护(24 个月对 6 个月)和单次植入的植入物表示偏好。他们表示,他们更喜欢可生物降解的植入物,在植入后 1 个月内可取出。受访者对插入位置没有偏好。总的来说,78%的受访者表示,如果有一种 PrEP 植入物可用,他们很可能(33%)或非常可能(45%)使用,大多数(82%)人表示更喜欢既能预防 HIV 又能预防意外怀孕的双重保护产品。为了降低感染 HIV 的风险,在我们的调查中,AG、YW 和 FSW 表示愿意使用长效、高效、可溶解的 PrEP 植入物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9327/9371991/5042e2a1cdde/10461_2022_3658_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9327/9371991/ae498ae1a3cf/10461_2022_3658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9327/9371991/a58594a7f85b/10461_2022_3658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9327/9371991/d9c1bad25b6d/10461_2022_3658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9327/9371991/5042e2a1cdde/10461_2022_3658_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9327/9371991/ae498ae1a3cf/10461_2022_3658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9327/9371991/a58594a7f85b/10461_2022_3658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9327/9371991/d9c1bad25b6d/10461_2022_3658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9327/9371991/5042e2a1cdde/10461_2022_3658_Fig4_HTML.jpg

相似文献

1
HIV Pre-exposure Prophylaxis Implant Stated Preferences and Priorities: Results of a Discrete Choice Experiment Among Women and Adolescent Girls in Gauteng Province, South Africa.HIV 暴露前预防植入的选择偏好和优先事项:南非豪登省妇女和少女参与的离散选择实验结果。
AIDS Behav. 2022 Sep;26(9):3099-3109. doi: 10.1007/s10461-022-03658-w. Epub 2022 Mar 31.
2
Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa.妇女和女童对长效避孕产品的偏好:在斯威士兰、肯尼亚和南非进行的定量调查和离散选择实验。
AIDS Behav. 2024 Mar;28(3):936-950. doi: 10.1007/s10461-023-04202-0. Epub 2023 Nov 16.
3
Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.南非青年对长效暴露前预防(PrEP)用于 HIV 预防的偏好:一项离散选择实验的结果。
J Int AIDS Soc. 2020 Jun;23(6):e25528. doi: 10.1002/jia2.25528.
4
End-user research in support of long-acting systemic antiretroviral delivery systems: insights from qualitative research with providers and target users in South Africa.支持长效系统抗逆转录病毒给药系统的终端用户研究:来自南非提供者和目标用户定性研究的见解。
BMC Infect Dis. 2022 Dec 8;22(1):919. doi: 10.1186/s12879-022-07907-0.
5
HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection.艾滋病毒预防不仅仅是关于艾滋病毒——在女性中进行离散选择实验,以建立模型,说明艾滋病毒预防产品的采用和效果也可能依赖于妊娠和性传播感染的保护。
BMC Infect Dis. 2020 Sep 25;20(1):704. doi: 10.1186/s12879-020-05399-4.
6
Perspectives of South African youth in the development of an implant for HIV prevention.南非青年在开发艾滋病毒预防植入物方面的观点。
J Int AIDS Soc. 2018 Aug;21(8):e25170. doi: 10.1002/jia2.25170.
7
Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).南非、乌干达和津巴布韦青春期少女和年轻女性对口服暴露前预防 (PrEP) 或双夫定阴道环用于 HIV 预防的基线偏好(MTN-034/IPM-045 研究)。
PLoS One. 2023 Jun 23;18(6):e0287525. doi: 10.1371/journal.pone.0287525. eCollection 2023.
8
The Global Impact of Diversifying PrEP Options: Results of an International Discrete Choice Experiment of Existing and Potential PrEP Strategies with Gay and Bisexual Men and Physicians.《多样化的 PrEP 选择对全球的影响:对男同性恋和双性恋者及医生使用现有和潜在 PrEP 策略的国际离散选择试验结果》。
AIDS Res Hum Retroviruses. 2024 Oct;40(10):591-605. doi: 10.1089/AID.2023.0120. Epub 2024 May 28.
9
Long-Acting Injection and Implant Preferences and Trade-Offs for HIV Prevention Among South African Male Youth.长效注射和植入预防南非男青年 HIV 的偏好和权衡。
J Acquir Immune Defic Syndr. 2021 Jul 1;87(3):928-936. doi: 10.1097/QAI.0000000000002670.
10
Incorporating end-users' voices into the development of an implant for HIV prevention: a discrete choice experiment in South Africa and Zimbabwe.将最终用户的声音纳入预防 HIV 植入物的开发中:南非和津巴布韦的离散选择实验。
BMC Womens Health. 2023 Feb 10;23(1):58. doi: 10.1186/s12905-023-02181-x.

引用本文的文献

1
Willingness of adolescent girls and young women to participate in future clinical trials of long-acting PrEP implants for HIV prevention, Kampala Uganda.乌干达坎帕拉青少年女孩和年轻女性参与长效HIV预防暴露前预防植入剂未来临床试验的意愿。
PLOS Glob Public Health. 2025 Aug 8;5(8):e0005028. doi: 10.1371/journal.pgph.0005028. eCollection 2025.
2
Preferences for Long-Acting HIV Pre-Exposure Prophylaxis among Women of Reproductive Age in Low- and Middle-income Countries: A Systematic Review.低收入和中等收入国家育龄妇女对长效艾滋病毒暴露前预防的偏好:一项系统评价
AIDS Behav. 2025 Jul 21. doi: 10.1007/s10461-025-04821-9.
3

本文引用的文献

1
Pills, Injections, Rings, or Implants? PrEP Formulation Preferences of PrEP-Experienced African Women for HIV Prevention.药丸、注射剂、阴道环还是植入剂?有使用暴露前预防(PrEP)经验的非洲女性对预防艾滋病毒的PrEP制剂偏好
J Acquir Immune Defic Syndr. 2021 Dec 1;88(4):e30-e32. doi: 10.1097/QAI.0000000000002793.
2
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.卡博特韦用于预防顺性别男性和跨性别女性中的 HIV。
N Engl J Med. 2021 Aug 12;385(7):595-608. doi: 10.1056/NEJMoa2101016.
3
Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention.
User preferences on long-acting pre-exposure prophylaxis for HIV prevention in Eastern and Southern Africa: a scoping review.
东非和南部非洲地区用户对长效暴露前预防艾滋病病毒的偏好:一项范围综述
BMC Public Health. 2025 Jul 3;25(1):2361. doi: 10.1186/s12889-025-23529-y.
4
Stated preferences of adolescents and young adults for sexual and reproductive health services in Africa: a systematic review.非洲青少年和青年对性与生殖健康服务的陈述性偏好:一项系统评价
Sex Reprod Health Matters. 2025 Dec;33(1):2520682. doi: 10.1080/26410397.2025.2520682. Epub 2025 Aug 1.
5
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review.健康经济学中离散选择实验的发展态势:一项系统综述
Pharmacoeconomics. 2025 May 21. doi: 10.1007/s40273-025-01495-y.
6
Qualitative focus group discussions exploring PrEP method and service delivery preferences among female sex workers and their managers in four Zambian provinces.在赞比亚四个省份对女性性工作者及其管理者进行的定性焦点小组讨论,探讨了暴露前预防方法和服务提供偏好。
BMJ Public Health. 2024 Feb 22;2(1):e000483. doi: 10.1136/bmjph-2023-000483. eCollection 2024 Jun.
7
Acceptability of an annual tenofovir alafenamide implant for HIV prevention in South African women: findings from the CAPRISA 018 Phase I clinical trial.南非女性中用于预防艾滋病的替诺福韦艾拉酚胺年度植入剂的可接受性:CAPRISA 018 I期临床试验结果
J Int AIDS Soc. 2025 Feb;28(2):e26426. doi: 10.1002/jia2.26426.
8
Assessing Non-Oral PrEP Alternatives Among Young Black Women in the Southern USA.评估美国南部年轻黑人女性中口服暴露前预防(PrEP)之外的其他预防措施
J Racial Ethn Health Disparities. 2025 Jan 6. doi: 10.1007/s40615-024-02263-y.
9
HIV Prevention Product Acceptability and Preference Among Women in Sub-Saharan Africa to Inform Novel Biomedical Options in Development: A Systematic Review.撒哈拉以南非洲地区女性对艾滋病预防产品的可接受性和偏好,为新型生物医学研发选项提供信息:一项系统综述
AIDS Behav. 2025 Jan;29(1):257-293. doi: 10.1007/s10461-024-04529-2. Epub 2024 Oct 18.
10
Stated preferences of adolescents and young adults for sexual and reproductive health services in Africa: a systematic review protocol.非洲青少年和年轻人对性健康和生殖健康服务的偏好的表述性研究:系统综述方案。
BMJ Open. 2024 Sep 10;14(9):e079502. doi: 10.1136/bmjopen-2023-079502.
长效注射剂、植入物和阴道环在避孕和预防 HIV 方面的进展。
Adv Drug Deliv Rev. 2021 Sep;176:113849. doi: 10.1016/j.addr.2021.113849. Epub 2021 Jun 27.
4
Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important.南非索韦托疫苗效力试验参与者使用艾滋病毒预防方法的意愿:谨慎很重要。
BMC Public Health. 2020 Nov 7;20(1):1669. doi: 10.1186/s12889-020-09785-0.
5
HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection.艾滋病毒预防不仅仅是关于艾滋病毒——在女性中进行离散选择实验,以建立模型,说明艾滋病毒预防产品的采用和效果也可能依赖于妊娠和性传播感染的保护。
BMC Infect Dis. 2020 Sep 25;20(1):704. doi: 10.1186/s12879-020-05399-4.
6
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.恩曲他滨和丙酚替诺福韦艾拉酚胺与恩曲他滨和富马酸替诺福韦二吡呋酯用于 HIV 暴露前预防(DISCOVER):一项随机、双盲、多中心、阳性对照、3 期、非劣效性临床试验的主要结果。
Lancet. 2020 Jul 25;396(10246):239-254. doi: 10.1016/S0140-6736(20)31065-5.
7
Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.南非青年对长效暴露前预防(PrEP)用于 HIV 预防的偏好:一项离散选择实验的结果。
J Int AIDS Soc. 2020 Jun;23(6):e25528. doi: 10.1002/jia2.25528.
8
Factors associated with HIV in younger and older adult men in South Africa: findings from a cross-sectional survey.南非年轻和老年男性人群中与 HIV 相关的因素:一项横断面调查的结果。
BMJ Open. 2019 Dec 23;9(12):e031667. doi: 10.1136/bmjopen-2019-031667.
9
Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.在南非,为注射式避孕使用者提供长效暴露前预防措施以预防 HIV 的流行病学影响和成本效益:一项建模研究。
J Int AIDS Soc. 2019 Dec;22(12):e25427. doi: 10.1002/jia2.25427.
10
Knowledge gaps of STIs in Africa; Systematic review.非洲性传播感染知识差距;系统评价。
PLoS One. 2019 Sep 12;14(9):e0213224. doi: 10.1371/journal.pone.0213224. eCollection 2019.